Howard Hughes Medical Institute’s Pentair PNR Stock Holding History
Bought
Maintained
Sold
Other funds holding PNR
VCM
VPM
Howard Hughes Medical Institute's PNR Position: Q1 2026 in Review
Howard Hughes Medical Institute sold out of Pentair (PNR) in Q1 2026, closing a stake of 35 shares — an estimated $3.65K sold.
Howard Hughes Medical Institute first reported a position in PNR in Q1 2014 and held it in 4 quarters. The position peaked at $11K in Q1 2014. 739 funds tracked by Wall St. Rank hold PNR as of Q1 2026.
- Howard Hughes Medical Institute reported no remaining Pentair position as of Q1 2026 after selling out during the quarter.
- Howard Hughes Medical Institute sold 35 Pentair shares in Q1 2026, an estimated $3.65K.
- Howard Hughes Medical Institute first reported a position in Pentair in Q1 2014 and held it in 4 quarters.
- Howard Hughes Medical Institute's Pentair position peaked at $11K in Q1 2014.
- 739 funds tracked by Wall St. Rank held Pentair as of Q1 2026.
Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.